Posts for NEUROCRINE BIOSCIENCES INC ($NBIX)

Showing 1 - 2 of 2 Posts

Neurocrine Biosciences Q4 2024 Financial Analysis: Strong Growth Amid Risks

$NBIX

•

Form 10-K

•

2025-02-10

Last updated: 3 months ago

Neurocrine Biosciences Q4 2024 Financial Analysis: Strong Growth Amid Risks

Explore Neurocrine Biosciences' Q4 2024 report highlighting $2.4B in revenue, $341M net income, and key risks. A must-read for investors focused on biopharmaceuticals.

Biopharmaceuticals Neurological Disorders INGREZZA R&D Investment Debt Management

Neurocrine Biosciences 8-K Report: Key Updates from December 20, 2024

$NBIX

•

Form 8-K

•

2024-12-20

Last updated: 5 months ago

Neurocrine Biosciences 8-K Report: Key Updates from December 20, 2024

Explore Neurocrine Biosciences' 8-K report detailing significant corporate changes and compliance updates as of December 20, 2024. Stay informed about NBIX's latest developments.

Neurocrine Biosciences biotechnology NASDAQ NBIX financial reporting SEC compliance